ARCHIVES

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 03 | January 17, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

CCOP Review Committee Member Objects To “Unwarranted Criticism”

March 4, 1988

Chaos In Congress Killed $20 Million Increase For NCI

December 19, 1980

Immunotherapy Demonstrates Disease Control in Phase II Study

September 28, 2012

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990